Glow (GHK-Cu / AHK-Cu / SNAP-8) Research Guide

Overview

What is Glow?

Glow is a proprietary skin rejuvenation blend combining three complementary peptides: GHK-Cu (50 mg), AHK-Cu (10 mg), and SNAP-8 (10 mg). Each component targets a different aspect of skin aging, creating a comprehensive approach to skin quality improvement that addresses collagen production, copper-mediated tissue remodeling, and expression line formation simultaneously.

GHK-Cu (glycyl-histidyl-lysine copper) is the primary component, providing the foundational collagen synthesis and gene expression modulation documented in over 4,000 studies. AHK-Cu (alanyl-histidyl-lysine copper) is a related copper tripeptide that shares GHK-Cu's copper-binding properties but with slightly different cell signaling characteristics. AHK-Cu has been shown to promote both collagen and elastin production, with some research suggesting it may be more potent than GHK-Cu for specific extracellular matrix proteins. The combination of both copper tripeptides provides broader coverage of the copper-dependent enzymatic pathways involved in skin remodeling.

SNAP-8 (Acetyl Octapeptide-3) adds a neuromuscular modulation component, reducing the repetitive muscle contractions that create expression lines. While GHK-Cu and AHK-Cu rebuild the dermal matrix from below, SNAP-8 addresses the mechanical forces that create surface wrinkles. This three-pronged approach targets the structural (collagen/elastin), enzymatic (copper delivery), and mechanical (muscle relaxation) dimensions of skin aging in a single formulation.

Science

Mechanism of Action

Glow addresses skin aging through three distinct but synergistic mechanisms, each targeting a different layer of the skin aging process.

GHK-Cu: Gene Expression Modulation & Collagen Synthesis

GHK-Cu is a naturally occurring tripeptide (Gly-His-Lys) that forms a complex with copper(II) ions. Found in human plasma, saliva, and urine, its concentration declines with age — from approximately 200 ng/mL at age 20 to 80 ng/mL by age 60. GHK-Cu has been shown to modulate the expression of over 4,000 genes, upregulating genes involved in collagen synthesis (types I, III, and V), decorin production, and metalloproteinase regulation. It promotes tissue remodeling by activating fibroblasts and stimulating new glycosaminoglycan (GAG) synthesis, increasing skin thickness and elasticity [1].

AHK-Cu: Enhanced Copper Delivery & Elastin Stimulation

AHK-Cu (alanyl-histidyl-lysine copper) is a copper tripeptide analog that mirrors GHK-Cu's copper-binding capability but with a different amino acid sequence that influences cellular uptake and receptor interaction. Research suggests AHK-Cu may be particularly effective at stimulating elastin synthesis, complementing GHK-Cu's primary collagen focus. The dual copper peptide approach ensures broader enzyme activation across lysyl oxidase (cross-linking collagen and elastin), superoxide dismutase (antioxidant defense), and cytochrome c oxidase (cellular energy) [2].

SNAP-8: SNARE Complex Modulation

SNAP-8 (Acetyl Octapeptide-3) is a synthetic octapeptide that mimics the N-terminal end of SNAP-25, a protein essential for the SNARE complex that mediates neurotransmitter release at the neuromuscular junction. By competing with native SNAP-25 for SNARE complex assembly, SNAP-8 reduces the efficiency of acetylcholine release at facial muscle motor end plates, attenuating the repetitive contractions that create expression lines (forehead, crow's feet, glabellar folds). This is the same mechanism targeted by botulinum toxin, but achieved through peptide competition rather than enzymatic cleavage [3].

Synergistic Three-Layer Approach

The blend's design philosophy addresses skin aging at three levels simultaneously: GHK-Cu and AHK-Cu rebuild the structural matrix from below (dermal remodeling), while SNAP-8 reduces the mechanical forces from above (expression line prevention). This "build and protect" approach means the newly synthesized collagen and elastin are not immediately degraded by the same repetitive folding patterns that caused the original lines. The result is a more durable improvement in skin quality compared to addressing either mechanism alone.

Dosing

Dosing Protocol

The Glow blend delivers proportional amounts of all three peptides per injection. Dosing focuses on consistent, moderate delivery over extended protocols to allow gradual dermal remodeling.

Protocol	Dose	Frequency	Duration	Notes
Standard	0.1–0.2 mL SubQ	Once daily	8–12 weeks	Delivers proportional blend of all three peptides
Facial focus	0.05–0.1 mL per area	3–5x per week	8–12 weeks	Target specific areas of concern (forehead, crow's feet)
Maintenance	0.1 mL SubQ	3x per week	Ongoing	Post-initial cycle maintenance

Dosing Notes
Results accumulate gradually over weeks. Visible skin quality improvements typically begin at 4–6 weeks and continue improving through week 12.
For targeted expression line reduction (SNAP-8 mechanism), injecting near the facial muscles of concern may enhance local effects.
There is no need to inject on an empty stomach — these peptides work locally, not through systemic hormonal pathways.
Expect a blue-green tint in the reconstituted solution from the copper complexes. This is completely normal.

Preparation

Reconstitution Guide

Reconstitute the lyophilized Glow blend with bacteriostatic water. The copper peptides dissolve readily and will impart a characteristic blue-green color to the solution.

Remove the plastic cap from the Glow vial and wipe the rubber stopper with an alcohol swab. Allow to dry.
Draw 2 mL of bacteriostatic water into a sterile syringe. For a 70 mg vial (50/10/10 mg), this yields a concentrated solution.
Insert the needle through the rubber stopper at a slight angle. Inject the water slowly against the inner wall of the vial — do not spray directly onto the peptide powder.
Allow the vial to sit for 1–2 minutes. Gently roll the vial between your palms if needed. Do not shake or vortex.
The solution will have a characteristic blue-green tint from the copper complexes. This is normal. Discard only if you observe particulate matter or unusual cloudiness.

70 mg vial + 2 mL BAC water: Each 0.1 mL delivers approximately 2.5 mg GHK-Cu + 0.5 mg AHK-Cu + 0.5 mg SNAP-8

0.1 mL dose = 10 units on a 100-unit insulin syringe

0.2 mL dose = 20 units on a 100-unit insulin syringe

Doses per vial: 20 doses at 0.1 mL, or 10 doses at 0.2 mL

Supplies Needed (8-Week Cycle at 0.1 mL Daily)
3 vials Glow (70 mg each) — provides 60 doses, covers 56 days with margin
3 vials bacteriostatic water (30 mL each)
60 insulin syringes (29–31 gauge, 100-unit)
Alcohol prep pads

Administration

Injection Technique

Glow is administered via subcutaneous (SubQ) injection. For skin rejuvenation goals, injection site selection can be strategic — injecting near target areas may enhance local peptide concentration.

Clean the injection site with an alcohol swab and allow it to air dry completely (approximately 30 seconds). Common sites: lower abdomen for systemic delivery, or near target facial areas for localized effects.
Draw the dose. Insert the needle into the vial through the rubber stopper. Invert the vial and draw the calculated number of units slowly. Tap the syringe to move any air bubbles to the top, then push them out gently.
Pinch the skin at the injection site to create a fold of subcutaneous tissue. Insert the needle at a 45-degree angle in a quick, smooth motion. Release the skin fold.
Inject slowly. Depress the plunger steadily over 5–10 seconds. Withdraw the needle at the same angle it was inserted. Apply gentle pressure with a clean swab if needed.

Temporary Discoloration

The copper peptide components may cause temporary blue-green discoloration at the injection site. This is a cosmetic effect from the copper complex and is completely harmless. It typically fades within 24–48 hours. For this reason, many researchers prefer abdominal or non-visible injection sites, rotating to facial-proximal sites only when targeting specific expression line areas.

Storage

Storage & Stability

Copper peptide complexes provide inherent stability advantages. The copper ion acts as a natural antimicrobial, extending the usable life of the reconstituted solution compared to many other peptides.

Lyophilized (Powder)

2–8°C (36–46°F)

Refrigerator. Stable for 24+ months sealed.

Lyophilized (Long-term)

-20°C (-4°F)

Freezer. Extended stability beyond 2 years.

Reconstituted

2–8°C (36–46°F)

Refrigerate immediately. Use within 28 days.

Avoid

Do not freeze reconstituted solution

Protect from light. Copper complexes are photosensitive.

Storage Tips
Keep vials upright and away from direct light — copper complexes can degrade under UV exposure.
The 28-day reconstituted window is longer than most peptides due to the copper ion's antimicrobial properties.
The blue-green color should remain consistent throughout the vial's life. Significant color change may indicate degradation.
Label reconstituted vials with the date to track the 28-day use window.

Safety

Side Effects & Considerations

All three components of Glow have individually well-documented safety profiles. Copper peptides in particular have extensive safety data from decades of topical cosmetic use.

Commonly Reported

Injection site blue-green discoloration — temporary, from the copper complexes. Fades within 24–48 hours.
Mild injection site irritation — redness, minor swelling. Typically self-resolving within 30 minutes.
Skin improvements develop gradually over 4–8 weeks. Do not expect immediate visible results.

Precautions

Avoid in individuals with Wilson's disease (genetic copper metabolism disorder) or known copper sensitivity.
SNAP-8's neuromuscular modulation is localized and temporary. It does not produce the same degree of muscle paralysis as botulinum toxin.
No systemic adverse effects are expected at standard cosmetic injection doses.
The copper components have antioxidant properties but should not be combined with high-dose antioxidant supplements without consideration of copper metabolism interactions.

Important

Glow is classified as a research product. It is not FDA-approved for any cosmetic or clinical indication. All information presented here reflects published preclinical research on the individual components and should not be construed as medical advice.

Protocols

Stacking Protocols

Glow is a comprehensive skin blend that already combines three complementary peptides. Additional stacking is less common but may focus on systemic support.

Glow + BPC-157 (Skin + Tissue Repair)

Adding BPC-157 introduces systemic tissue repair and angiogenesis, potentially enhancing nutrient delivery to skin tissues. BPC-157's growth factor upregulation may complement the copper peptides' collagen synthesis effects.

Peptide	Dose	Frequency	Duration
Glow	0.1 mL SubQ	Once daily	8–12 weeks
BPC-157	250 mcg	Once daily	4–8 weeks

Lifestyle Factors for Skin Rejuvenation

Sun protection: UV radiation is the primary driver of extrinsic skin aging. Consistent broad-spectrum sunscreen use is essential to preserve the collagen and elastin gains from peptide therapy.
Hydration: Adequate water intake supports dermal hydration and glycosaminoglycan function.
Sleep: Skin repair and collagen synthesis peak during sleep. Prioritize 7–9 hours to maximize results.
Retinoid synergy: Topical retinoids (retinol, tretinoin) upregulate collagen gene expression through a different pathway than copper peptides. The combination may produce additive effects, though timing should be separated to avoid irritation.

Researchers studying Glow often investigate these related compounds:

References

Literature & Citations

Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108. PubMed
Gorouhi F, Maibach HI. Role of topical peptides in preventing or treating aged skin. Int J Cosmet Sci. 2009;31(5):327-345. PubMed
Blanes-Mira C, Clemente J, Jodas G, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. Int J Cosmet Sci. 2002;24(5):303-310. PubMed
Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987. PubMed
Hussain M, Goldberg DJ. Topical manganese peptide in the treatment of photodamaged skin. J Cosmet Laser Ther. 2007;9(4):232-236. PubMed
Lintner K, Mas-Chamberlin C, Mondon P, et al. Cosmeceuticals and active ingredients. Clin Dermatol. 2009;27(5):461-468. PubMed
Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988. PubMed

Glow (GHK-Cu / AHK-Cu / SNAP-8)